Handelsbanken Fonder Ab Precigen, Inc. Transaction History

Handelsbanken Fonder Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$1.15 - $2.53 $59,229 - $130,305	-51,504 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$3.53 - $5.5 $133,787 - $208,450	37,900 Added 278.59%	51,504 $191,000
Q2 2021 Aug 03, 2021	SELL	$6.24 - $8.22 $7,488 - $9,864	-1,200 Reduced 8.11%	13,604 $89,000
Q2 2020 Aug 13, 2020	BUY	$2.16 - $5.46 $31,976 - $80,829	14,804 New	14,804 $74,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.